Matinas Biopharma Hl (MTNB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2017 | 03-2017 | 12-2016 | 09-2016 | 06-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -8,464 | -4,496 | -7,599 | -5,707 | -3,869 |
| Depreciation Amortization | 25 | 12 | 53 | 40 | 26 |
| Accounts receivable | 5 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | -22 | 772 | -22 | -288 | -22 |
| Other Working Capital | -8 | 80 | -94 | 388 | 410 |
| Other Operating Activity | 1,705 | 600 | 1,543 | 1,565 | 817 |
| Operating Cash Flow | $-6,759 | $-3,032 | $-6,119 | $-4,003 | $-2,637 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -790 | N/A | N/A | N/A | N/A |
| Investing Cash Flow | $-790 | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -124 | -73 | -160 | -87 | -12 |
| Common Stock Issued | 14,834 | 14,834 | 315 | 240 | N/A |
| Other Financing Activity | 0 | 0 | 6,842 | 6,842 | 0 |
| Financing Cash Flow | $14,710 | $14,761 | $6,997 | $6,995 | $-12 |
| Beginning Cash Position | 4,797 | 4,797 | 3,227 | 3,227 | 3,227 |
| End Cash Position | 11,958 | 16,526 | 4,106 | 6,220 | 578 |
| Net Cash Flow | $7,161 | $11,729 | $879 | $2,993 | $-2,649 |
| Free Cash Flow | |||||
| Operating Cash Flow | -6,759 | -3,032 | -6,119 | -4,003 | -2,637 |
| Capital Expenditure | -790 | N/A | N/A | N/A | N/A |
| Free Cash Flow | -7,549 | -3,032 | -6,119 | -4,003 | -2,637 |